Navigation Links
TGen and Scottsdale Healthcare cancer expert Dr. Daniel D. Von Hoff is honored by ASCO

PHOENIX, Ariz. March 7, 2014 In association with its 50th anniversary, the American Society of Clinical Oncology (ASCO) has named Dr. Daniel D. Von Hoff one of ASCO's 50 Oncology Luminaries, celebrating 50 doctors who over the past half-century have significantly advanced cancer care.

Dr. Von Hoff, M.D., FACP, is Physician-In-Chief and Distinguished Professor at Phoenix-based Translational Genomics Research Institute (TGen), and Chief Scientific Officer for Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials. He is an internationally recognized physician and scientist whose research during the past 30 years has contributed to the development of many anticancer agents that are routinely used in clinical practice. Among these drugs are fludarabine, mitoxantrone, paclitaxel, docetaxel, irinotecan, topotecan, nelarabine, gemcitabine, vismodegib, and nanoparticle paclitaxel.

ASCO was founded in 1964 by oncologists to improve the care of cancer patients. Profiles of the 50 Oncology Luminaries are being featured on the ASCO website, and their accomplishments will be celebrated at ASCO's 50th annual meeting, May 30-June 3 in Chicago.

Although it is difficult to pick one highlight of his career, Dr. Von Hoff and his team played an instrumental role in the development of gemcitabine, the first drug to improve the survival of patients with stage IV pancreatic cancer. In 1997, they published the results of a clinical trial that showed that gemcitabine not only increased the rate of clinical benefit in patients with pancreatic cancer compared with fluorouracil (5-FU), but it also improved overall survival.

This work was followed by recognition of the activity of nab-paclitaxel plus gemcitabine against pancreatic cancer with the recent finding that that regimen also improved survival for patients with stage IV pancreatic cancer. On Sept. 6, 2013, the U.S. Food and Drug Administration (FDA) approved nab-paclitaxel as a frontline therapy for patients with advanced pancreatic cancer.

International clinical trials that led to the FDA's approval were led by Dr. Von Hoff at Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership of Scottsdale Healthcare and TGen, at Scottsdale Healthcare Shea Medical Center in Scottsdale, Ariz.

Dr. Von Hoff has also been instrumental in the concept of development of personalized therapy for patients with refractory cancer based on using molecular techniques to profile their cancers. This work included the initial clinical trials to determine what percentage of patients could benefit from that approach.

Dr. Von Hoff has spent the past 30 years of his career leading teams in phase I trials and the development of new therapies, first as the founding director of the Institute for Drug Development at the Cancer Therapy and Research Center in San Antonio, then as the director of the Cancer Center and Professor of Medicine at the University of Arizona. He also is Professor of Medicine at the Mayo Clinic and serves as Chief Scientific Officer for US Oncology.

When Dr. Von Hoff was awarded ASCO's David A. Karnofsky Memorial Award in 2010, he took several minutes at the beginning of his lecture to memorialize all of the patients that he and his team had lost during phase I trials the previous year, mentioning several of them by name. The gesture reflected what Dr. Von Hoff named as the greatest accomplishment of his career: working hard to help as many people as he could.

"I have been extremely fortunate to have many great (and incredibly patient) teachers, mentors, and co-workers," Dr. Von Hoff said. "Truly though I think the greatest teachers and mentors for me have been those I have been privileged to care for."


Contact: Steve Yozwiak
The Translational Genomics Research Institute

Related medicine news :

1. Scottsdale Treatment Center Launches Program to Address Illicit Drug Use in Adults, Adolescents
2. Home Care Assistance of Scottsdale Launches New Website
3. Luxury Arizona Condos from The Statesman Group are Now Available for Purchase in Scottsdale/Phoenix, Arizona
4. Top Phoenix Hearing Aid Provider Opens New Office in Scottsdale, AZ
5. Younan Properties Announces Successful Financing of Scottsdale Shopping Center; Retail Promenade to be Renamed 7 Thousand Shea
6. Alice Branton Invites the Eyes of the World to Focus on Scottsdale, Arizona
7. Arizona Marijuana Doctor Helps Scottsdale Patients Achieve Green Wellness in the Copper State
8. Mahendra Kumar Trivedi to Host Retreat in Scottsdale, Arizona
9. TGen-TD2-Scottsdale Healthcare breast cancer pilot study shows value of proteomic mapping
10. Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley
11. Renowned Jewelry Designer Kendra Scott Hosted a Successful ‘Kendra Gives Back’ Party Benefitting Colleen’s Dream Foundation in Scottsdale, AZ
Post Your Comments:
Related Image:
TGen and Scottsdale Healthcare cancer expert Dr. Daniel D. Von Hoff is honored by ASCO
(Date:12/1/2015)... ... ... It’s official: Tattoo taboo is a thing of the past. One in ... whopping one in three aged 18 to 25 is inked). As tattoos transition to ... In fact, RealSelf , the world’s largest community for learning and sharing information ...
(Date:12/1/2015)... ... December 01, 2015 , ... The workstation ... lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s first portable DICOM-calibrated ... from November 29 to December 4, 2015. , MED-TAB is expected to ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic foot wounds are ... are well aware that psychology-based patient non-compliance (disobedience of a health care provider’s ... diseases of the diabetic foot. The American Board of Multiple Specialties in ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance ... imaging is the focus of numerous abstracts accepted for presentation here, at the ... Nine abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software ...
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays ... film for accurate interpretation by the radiologist. The marking utensils are so small, ... Calif., has found a way to alleviate this problem. , He developed the ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  The migration to ... develop shared care plans that help patients stay ... plans will be digitally enabled, incorporate care guidelines ... and desires. They will also allow all stakeholders ... health journey is optimal. That is the vision, ...
(Date:12/1/2015)...  Booth #3506 – Claymount is featuring its full line ... the Radiological Society of North America ... in the Netherlands , Claymount is part ... VAR ) and is one of the world,s leading ... automatic exposure control systems for controlling dose during medical X-ray ...
(Date:12/1/2015)... -- ) has announced ... Emergency Response System (PERS) Market by Type, by ... report to their offering. --> ... "Medical Alert Systems/Personal Emergency Response System (PERS) Market ... Global Forecas" report to their offering. ...
Breaking Medicine Technology: